Filing Details

Accession Number:
0001209191-19-023521
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-04-03 19:42:12
Reporting Period:
2019-04-01
Accepted Time:
2019-04-03 19:42:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1755237 Cyclerion Therapeutics Inc. CYCN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1478244 G Mark Currie C/o Cyclerion Therapeutics, Inc.
301 Binney Street
Cambridge MA 02142
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-04-01 51,648 $0.00 51,648 No 4 A Direct
Common Stock Acquisiton 2019-04-02 270,107 $14.81 321,755 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2019-04-01 888 $0.00 888 $12.39
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2019-04-01 37,286 $0.00 37,286 $12.23
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2019-04-01 17,491 $0.00 17,491 $16.21
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2019-04-01 27,773 $0.00 27,773 $14.40
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2019-04-01 9,930 $0.00 9,930 $15.54
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2019-04-01 13,125 $0.00 13,125 $17.20
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2019-04-01 2,500 $0.00 2,500 $17.20
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2019-04-01 50,801 $0.00 50,801 $11.28
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2019-04-01 113,430 $0.00 113,430 $18.46
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2019-04-01 141,007 $0.00 141,007 $16.02
Common Stock Employee Stock Option (Right to Buy) Acquisiton 2019-04-01 514,786 $0.00 514,786 $14.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
888 2020-02-02 No 4 A Direct
37,286 2021-02-01 No 4 A Direct
17,491 2022-02-01 No 4 A Direct
27,773 2023-02-01 No 4 A Direct
9,930 2024-03-03 No 4 A Direct
13,125 2025-03-16 No 4 A Direct
2,500 2025-03-16 No 4 A Direct
50,801 2026-03-01 No 4 A Direct
113,430 2027-02-27 No 4 A Direct
141,007 2028-02-21 No 4 A Direct
514,786 2029-01-29 No 4 A Direct
Footnotes
  1. In connection with the separation (the "Separation") of Cyclerion Therapeutics, Inc. ("Cyclerion") from Ironwood Pharmaceuticals, Inc. ("Ironwood"), the reporting person received Cyclerion shares representing an equitable adjustment of Ironwood shares held by the reporting person prior to the Separation.
  2. Represents options to purchase shares of Cyclerion common stock granted to the reporting person in connection with the Separation.
  3. This option, granted as an annual performance award, is presently exercisable in full.
  4. This option to purchase 25,212 shares vests in equal installments upon achievement of certain regulatory and commercial milestones. The option has vested as to 2,500 shares as of the date hereof.
  5. The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2016.
  6. The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2017.
  7. The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2018.
  8. The option, granted as an annual performance award, vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 1, 2019.